Pulike Biological Engineering, Inc. (SHA:603566)

China flag China · Delayed Price · Currency is CNY
11.59
-0.19 (-1.61%)
May 12, 2026, 3:00 PM CST
Market Cap3.96B -16.0%
Revenue (ttm)1.06B -2.3%
Net Income172.82M +46.0%
EPS0.50 +44.4%
Shares Out341.92M
PE Ratio23.12
Forward PE23.18
Dividend0.40 (3.40%)
Ex-Dividend DateOct 17, 2025
Volume4,661,465
Average Volume4,007,188
Open11.81
Previous Close11.78
Day's Range11.51 - 11.83
52-Week Range11.51 - 15.79
Beta0.44
RSI29.92
Earnings DateApr 29, 2026

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 1,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603566
Full Company Profile

Financial Performance

In 2025, SHA:603566's revenue was 1.09 billion, an increase of 4.54% compared to the previous year's 1.04 billion. Earnings were 184.99 million, an increase of 99.33%.

Financial Statements